Skip to main content

Table 1 Direct targets of NE-dependent regulation

From: Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease

Immunological targets

Activated by cleavage

Inhibited by cleavage

 Arginase-1 [106]

 CD2/CD4/CD8 [107]

 Chemerin [161]

 CD14 [162]

 IL-36 receptor antagonist [163]

 CD16 [164]

 IL-8 [84]

 CD43 [165]

 MMP-9 [67]

 CCL3 [166]

 PAR-1/PAR-2 [167, 168]

 Complement factors [169–172]

 Pro-IL-1β [173]

 CXCL12 [174]

 Transient receptor potential vanilloid 4 [67]

 CXCR1 [82]

 Tumor growth factor α [175]

 IgA [70] and IgG [71, 72]

 

 IL-2 receptor [108]

 

 IL-6 [176, 177]

 

 IL-8 [86]

 

 PAR-3 [168]

 

 Progranulin [178, 179]

 

 TIMP-1/TIMP-2/TIMP-3 [180, 181]

Non-immunological targets

Activated by cleavage

Inhibited by cleavage

 α2β3 integrins [182]

 Cadherins [183]

 EGFR [184]

 Elastin [185]

 ENaC [186, 187]

 Ferritin [188]

 

 Fibrin stabilizing factor XIII [189]

 

 Surfactant protein A [190]

 

 Surfactant protein D [191]

 

 Vascular endothelial growth factor [192]

  1. EGFR epidermal growth factor receptor, ENaC epithelial sodium channel, PAR protease-activated receptor, TIMP tissue inhibitor of metalloproteinase